Access this article Similar content being viewed by others References Correale M, Leopizzi A, Mallardi A, Ranieri A, Suriano MP, DAlessandro D, Tricarico L, Mazzeo P, Tucci S, Pastore G, Maulucci G, Di Biase M, Brunetti ND (2020) Switch to direct anticoagulants and improved endothelial function in patients with chronic heart failure and atrial fibrillation
Autophagy 19 26392656
Xu B, Dai W, Liu L, et al
The pleiotropic effects of sodiumglucose cotransporter-2 inhibitors: Beyond the glycemic benefit
According to FDA guidance: The limitations in section 503A(b)(1)(D) apply to the compounding of drug products that are essentially copies of a commercially available drug productnot only to drugs that are exact copies or even to drugs that are nearly identical